FightMND

Status: Open

Find out information about the aims, funding, key dates, resources and contacts for the FightMND Grants and Fellowships.

Research Services

Contact the research managers for faculty-specific processes

Workshops and online resources about funding applications

Macquarie research management system Pivot Research Professional (Pivot-RP)

Researchers working in areas relevant to improving the translation or progressing the development of potential therapies for Motor Neurone Disease (MND) are invited to apply for funding to support research projects commencing in 2025.

FightMND Fellowships aim to support researchers with outstanding ability to choose or continue to focus on MND as their selected field of endeavour. The essential purpose of the fellowships is to provide the opportunity for MND researchers with relevant experience and demonstrated expertise and ability, to apply for funding in their own name, build collaborations and further establish themselves as a MND researcher.

Clinical Trial Grants support Phase II/III clinical trials of novel, high-potential treatments for MND/ALS within the Australian Clinical Trials Consortium (Letter of Intent required. Closed 16 December 2024).

Drug Development Grants support preclinical research, development and assessment of therapeutics for MND/ALS through to (and including) completion of Phase I clinical trials. (Letter of Intent required. Closed 16 December 2024).

IMPACT Grants seek to support projects focused on overcoming one or more of the key challenges hindering the translation of promising discoveries into effective therapeutics, with the goal of improving the likelihood of positive clinical trial outcomes.

Discovery Grants support projects focused on defining the underlying cause(s) of MND, and/or understanding the fundamental disease mechanisms contributing to the progression of MND.

Early Career Fellowship: a 4-year full-time Fellowship up to a total of AUD $545,000.

Bill Guest Mid-Career Fellowship: a 4-year full-time Fellowship offering a total of AUD $180,000 per annum, with an overall maximum budget of AUD $720,000 over 4 years.

Clinical Trial Grants: up to AUD $1,800,000 (Phase II/III trial), with project performance of up to 3 years.

Drug Development Grants:

Stage 1: awarded with an offer of up to $550,000 in support for 3-year projects to identify and validate a lead candidate for further development for MND.
Stage 2: awarded with an offer of up to $1,200,000 in support for 3-year projects where a lead candidate with strong preclinical evidence is in hand.

IMPACT Grants: support 2-year projects up to the value of $300,000 AUD. Proposals must reflect translational stage research.

Discovery Research Grants: offered to a value of between AUD $250,000 and $1,000,000, with a project period of up to 3 years

FightMND will only accept applications submitted via the Fluxx Grant Management System, which can be accessed at the following link https://fightmnd.fluxx.io.

The key dates for FightMND applications are as follows:

Application Open: 04 November 2024
Letter of Intent* due: 16 December 2024 at 17:00 AEDT (For Clinical Trials and Drug Development Grants only)
Invitation to submit full application*: 20 December 2024 (For Clinical Trials and Drug Development Grants only)
GDT Strategic Review Period: 24 February – 28 February 2025 (optional GDT service); Book here
GDT Compliance & Eligibility Check Period: 10 March – 14 March 2025 (mandatory GDT service); Book here
Full applications due (all schemes): 24 March 2025 at 17:00 AEDT via Fluxx
Recipients notified: August 2025